Papp-Lantos inclusions and the pathogenesis of multiple system atrophy: an update.
about
Multiple system atrophy: a clinical and neuropathological perspectiveGlia and alpha-synuclein in neurodegeneration: A complex interactionAntidepressants reduce neuroinflammatory responses and astroglial alpha-synuclein accumulation in a transgenic mouse model of multiple system atrophyHDAC6 inhibition results in tau acetylation and modulates tau phosphorylation and degradation in oligodendrocytesSystemic proteasome inhibition triggers neurodegeneration in a transgenic mouse model expressing human α-synuclein under oligodendrocyte promoter: implications for multiple system atrophy.Towards translational therapies for multiple system atrophyThe neuropathology, pathophysiology and genetics of multiple system atrophy.Multiple system atrophy: current and future approaches to managementIncreased neuronal α-synuclein pathology associates with its accumulation in oligodendrocytes in mice modeling α-synucleinopathiesModelling progressive autonomic failure in MSA: where are we now?Models of multiple system atrophyCorticobasal degeneration with olivopontocerebellar atrophy and TDP-43 pathology: an unusual clinicopathologic variant of CBD.Inflammatory pre-conditioning restricts the seeded induction of α-synuclein pathology in wild type mice.Glial dysfunction in the pathogenesis of α-synucleinopathies: emerging concepts.The role of glia in α-synucleinopathies.Inclusion body formation, macroautophagy, and the role of HDAC6 in neurodegeneration.The function of α-synuclein.Neuropathology of multiple system atrophy: new thoughts about pathogenesis.Diagnosis and differential diagnosis of MSA: boundary issues.Protein aggregate formation in oligodendrocytes: tau and the cytoskeleton at the intersection of neuroprotection and neurodegeneration.Multiple system atrophy: pathogenic mechanisms and biomarkers.Mitochondrial impairment and oxidative stress compromise autophagosomal degradation of α-synuclein in oligodendroglial cells.Inhibition of UCH-L1 in oligodendroglial cells results in microtubule stabilization and prevents α-synuclein aggregate formation by activating the autophagic pathway: implications for multiple system atrophy.Oxidative stress promotes uptake, accumulation, and oligomerization of extracellular α-synuclein in oligodendrocytes.Multiple system atrophy: insights into a rare and debilitating movement disorder.Screening of Toll-like receptors expression in multiple system atrophy brains.Involvement of macroautophagy in multiple system atrophy and protein aggregate formation in oligodendrocytes.Identification and quantification of oligodendrocyte precursor cells in multiple system atrophy, progressive supranuclear palsy and Parkinson's disease.Preliminary report of multiple cell therapy for patients with multiple system atrophy.Multiple system atrophy: experimental models and reality.Progressive striatonigral degeneration in a transgenic mouse model of multiple system atrophy: translational implications for interventional therapies.Potential clinical utility of multiple system atrophy biomarkers.The Relevance of Iron in the Pathogenesis of Multiple System Atrophy: A Viewpoint.Behavioral and histological analysis of a partial double-lesion model of parkinson-variant multiple system atrophy.Four-repeat tauopathy clinically presenting as posterior cortical atrophy: atypical corticobasal degeneration?Minimal change multiple system atrophy: an aggressive variant?Medullary neuronal loss is not associated with α-synuclein burden in multiple system atrophy.Increase of the plasma α-synuclein levels in patients with multiple system atrophy.Multiple System Atrophy: An Oligodendroglioneural Synucleinopathy.Altered α-synuclein, parkin, and synphilin isoform levels in multiple system atrophy brains.
P2860
Q26829838-8F718E78-94E9-48A1-A313-384FDA0EDBD2Q26851153-4F333ABD-1AE2-4E6E-9DDF-EEB09C6EA0B5Q28395248-CAB26DD2-5B3C-465C-BD9E-801B9CA6FFDBQ28575023-F8EC748A-1B43-4A1C-85DB-EAA541280A25Q30516504-F575D290-DCC5-460A-B0E8-D3693125C4C5Q33797532-BA191A12-B80F-481B-A052-91952A16004DQ34231585-19C6C8B2-8F36-4D1B-9118-F31B171E9ADBQ34409502-E516DE0E-6AC5-4CDA-93EC-DEDC27FBA1E4Q34450431-4A1D6C6D-1FC6-4785-AE5E-FDF6D7F675EAQ34626244-24632A4E-8011-4F09-ABDE-B6FA22435987Q36513407-73514173-530D-4E62-8328-1612508929E2Q36788234-0EE371F4-3D3F-4D1B-8652-1D3D008D671BQ37555992-AB6219E9-AB7B-42C3-A8AF-89BF4223AB21Q37874476-228231C4-11E9-44B5-A2AF-7D3674DC35D9Q38039880-0DAD2735-7F07-418C-9BE1-396BFC6445C5Q38126332-E18F3977-CBEF-4997-BAB1-28110A230E69Q38139561-96C9AE90-6741-4509-A86C-9D6A9AE3B6CCQ38258246-A9E7FB11-768C-43FB-8F24-0AE75C295998Q38348584-662D1347-8BCF-471F-9F7C-9381818E9ADFQ38530227-98975DC1-AF80-4503-8D00-44653E638743Q38813304-7F325F30-A25C-477C-8205-FDCE645B5D2BQ38849169-91DB6A6B-53CA-455D-863A-C003A0B8936EQ38872092-86628D9E-A30A-43C7-B609-2FAAA18FF430Q39064365-5DF98FAB-339A-460D-8ACF-EFC1C8CFD964Q39183459-2237183C-5199-4E1E-BDE4-7F5C38BEEAD1Q44294417-22927C5F-78B4-4EB5-B732-F4D76A58807CQ44539585-5E711702-E2E7-48F3-9A95-83DBBA1732AFQ44625317-ABDDF523-DDAC-402D-94E3-D2E6448017F1Q45281992-EA3354DB-2CCE-4A86-B67B-9167E26C54D1Q46726761-3B53FDAA-1F4A-40BE-B010-FC7B5DBF4E36Q47252776-F0D52944-203E-4C44-A9BC-ED11B9343516Q47663712-66EA3846-2D5D-426C-9D9E-BC353B19F9A0Q47835285-FB407638-81CC-462F-9D3A-6F79F2E5A113Q47925610-DF0331A8-29FA-4B97-A91B-D81CABFD7E23Q48155467-50C9C5B9-E69A-4E80-B034-AE31D505B98CQ48239637-1AE1DA40-3466-49DD-809B-8291801F57F3Q48513255-018FB0EE-EF56-4324-A802-F7D13AF3A814Q48942077-14AA0EA8-F2AD-4E55-AC30-810B3FD5FD9FQ49562668-F3294D09-5BFB-4FCC-B617-FB88BCFB624BQ52147948-60FBD56F-9FDA-4317-9832-D327A9F823C3
P2860
Papp-Lantos inclusions and the pathogenesis of multiple system atrophy: an update.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 23 March 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Papp-Lantos inclusions and the pathogenesis of multiple system atrophy: an update.
@en
Papp-Lantos inclusions and the pathogenesis of multiple system atrophy: an update.
@nl
type
label
Papp-Lantos inclusions and the pathogenesis of multiple system atrophy: an update.
@en
Papp-Lantos inclusions and the pathogenesis of multiple system atrophy: an update.
@nl
prefLabel
Papp-Lantos inclusions and the pathogenesis of multiple system atrophy: an update.
@en
Papp-Lantos inclusions and the pathogenesis of multiple system atrophy: an update.
@nl
P2860
P1476
Papp-Lantos inclusions and the pathogenesis of multiple system atrophy: an update.
@en
P2093
Kurt A Jellinger
Peter L Lantos
P2860
P2888
P304
P356
10.1007/S00401-010-0672-3
P577
2010-03-23T00:00:00Z